Search

Daniel B Yarosh

from Merrick, NY
Age ~70

Daniel Yarosh Phones & Addresses

  • 2915 Shore Dr, Merrick, NY 11566 (516) 384-4974
  • Delray Beach, FL
  • Brooklyn, NY
  • New York, NY
  • Freeport, NY
  • Gaithersburg, MD
  • Nassau, NY
  • 2915 Shore Dr, Merrick, NY 11566

Work

Company: Applied genetics inc Address: 205 Buffalo Ave, Freeport, NY 11520 Phones: (516) 868-9026 Position: Owner Industries: Drugs, Drug Proprietaries, and Druggists' Sundries

Resumes

Resumes

Daniel Yarosh Photo 1

Sr Vp Basic Science Research At Estee Lauder

View page
Location:
Greater New York City Area
Industry:
Cosmetics
Daniel Yarosh Photo 2

President At Agi Dermatics

View page
Location:
Greater New York City Area
Industry:
Biotechnology

Business Records

Name / Title
Company / Classification
Phones & Addresses
Daniel Yarosh
Owner
Applied Genetics Inc
Drugs, Drug Proprietaries, and Druggists' Sun...
205 Buffalo Ave, Freeport, NY 11520
Website: agiderm.com,
Daniel Yarosh
Senior Vice President
The Estee Lauder Companies Inc
Perfumes, Cosmetics, and Other Toilet Prepara...
767 5Th Ave Fl 36, New York, NY 10153
Daniel B Yarosh
Owner
Applied Genetics Inc
Biotechnology · Druggists' Goods Merchant Whols · Pharmaceutical Products-Wholes
205 Buffalo Ave, Freeport, NY 11520
(516) 868-9026, (516) 868-9143
Daniel Yarosh
President, Director
Agi Dermatics
Biotechnology · To Produce, Distribute, Purchase, Market And Sell Cosmetics And Haircare Products Of Any Kind And Any Products And Services Related Thereto. · Nonclassifiable Establishments · Noncommercial Research Organization Testing Laboratory Mfg Pharmaceutical Preparations
205 Buffalo Ave, Freeport, NY 11520
7 Corporate Ctr Dr, Melville, NY 11747
C/O Csc, Wilmington, DE 19808
7 Corporate Ctr Dr Attn Tax Dept, Melville, NY 11747
(631) 847-6213
Daniel Yarosh
Owner
Applied Genetics Inc
Drugs, Drug Proprietaries, and Druggists' Sun...
205 Buffalo Ave, Freeport, NY 11520
Website: agiderm.com,
Daniel Yarosh
Senior Vice President
The Estee Lauder Companies Inc
Perfumes, Cosmetics, and Other Toilet Prepara...
767 5Th Ave Fl 36, New York, NY 10153

Publications

Amazon

New Science Of Perfect Skin Understanding Skin Care Myths And Miracles For Radiant Skin At Any Age By Daniel Yarosh [Harmony,2008] [Hardcover]

New Science of Perfect Skin Understanding Skin Care Myths and Miracles For Radiant Skin at Any Age by Daniel Yarosh [Harmony,2008] [Hardcover]

View page
Author

Daniel Yarosh

Binding

Hardcover

Publisher

Harmony,2008

ISBN #

2

The New Science Of Perfect Skin: Understanding Skin Care Myths And Miracles For Radiant Skin At Any Age

The New Science of Perfect Skin: Understanding Skin Care Myths and Miracles For Radiant Skin at Any Age

View page

This book is about the New Skin-Care Revolution. The good news is that today there are products that really work. The bad news is that there’s never been more confusion and uncertainty about which products get results and which are a waste of money and time. Consumers are bombarded by enticing ads f...

Author

Daniel Yarosh

Binding

Hardcover

Pages

304

Publisher

Harmony

ISBN #

0767925394

EAN Code

9780767925396

ISBN #

1

Skin photoaging and DNA repair.(deoxyribonucleic acid): An article from: Dermatology Nursing

View page

This digital document is an article from Dermatology Nursing, published by Thomson Gale on June 1, 2007. The length of the article is 775 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker...

Author

Daniel B. Yarosh

Binding

Digital

Pages

3

Publisher

Thomson Gale

ISBN #

3

The New Science of Perfect Skin: Understanding Skin Care Myths and Miracles For

View page
Author

Daniel Yarosh

Binding

Hardcover

Publisher

Broadway

ISBN #

4

Us Patents

Methods And Compositions For The Protection Of Mitochondria

View page
US Patent:
6479533, Nov 12, 2002
Filed:
Dec 1, 1999
Appl. No.:
09/452585
Inventors:
Daniel B. Yarosh - Merrick NY
Assignee:
Applied Genetics Incorporated Dermatics - Freeport NY
International Classification:
A61K 3415
US Classification:
514398, 424 91
Abstract:
Protection of mitochondria from oxidative damage due to natural or disease processes as well as by the effects of exogenous factors such as incident sunlight, exposure via inhalation to oxidative environmental toxins, consumption of dietary oxidants, and oxidative-stress-inducing cosmetics and pharmaceuticals, radiation therapy, among others, is provided by a composition comprising L-ergothioneine, L-ergothioneine may be prepared in a cosmetically or pharmaceutically-acceptable base to form an agent for topical application to the skin, and for oral or parenteral administration. Effective application and delivery, of L-ergothioneine is enhanced by encapsulation in a liposomes, a preferred embodiment. Diagnostic methods for determining exposure and susceptibility to radiation, radical and reactive oxygen species in mammals is also provided.

Compositions And Methods For Modification Of Skin Lipid Content

View page
US Patent:
6982284, Jan 3, 2006
Filed:
Sep 8, 2000
Appl. No.:
10/070466
Inventors:
David A. Brown - Merrick NY, US
Daniel B. Yarosh - Merrick NY, US
Assignee:
Applied Genetics Incorporated Dermatics - Freeport NY
International Classification:
A61K 31/185
A61K 31/20
A61K 31/56
US Classification:
514577, 514169, 514560
Abstract:
The topical use of ursolic acid compounds to alter the lipid content of mammalian skin is disclosed. The compounds can be encapsulated in liposomes and administered in this form to the skin in, for example, a lotion or a gel. The compounds are effective in, among other things, reducing the effects of aging, photoaging, and skin atrophy, including skin atrophy resulting from the topical use of retinoids and/or steroids. Compositions comprising a ursolic acid compound in combination with another therapeutically active topical compounds, such as, a retinoid or a steroid, are also disclosed.

Stabilization Of T4 Endonuclease V

View page
US Patent:
7094560, Aug 22, 2006
Filed:
Sep 20, 2002
Appl. No.:
10/490397
Inventors:
Anne B. Brown - Merrick NY, US
David A. Brown - Merrick NY, US
Daniel B. Yarosh - Merrick NY, US
Assignee:
Applied Genetics Incorporated Dermatics - Freeport NY
International Classification:
C12Q 1/37
C12N 9/22
US Classification:
435 23, 435199
Abstract:
The invention provides T4 endonuclease V compositions that exhibit enhanced stability, including stability at non-refrigerated temperatures, through reduced activity of cryptic proteases. Methods for detecting cryptic protease activity and methods for reducing such activity are also provided.

Biomimetic Of Fruit Extract For Amelioration Of Inflammation

View page
US Patent:
7655659, Feb 2, 2010
Filed:
Aug 11, 2005
Appl. No.:
11/660283
Inventors:
Daniel B. Yarosh - Merrick NY, US
David A. Brown - Merrick NY, US
Matthew T. Canning - East Meadow NY, US
Assignee:
Applied Genetics Incorporated Dermatics - Freeport NY
International Classification:
A61K 31/497
A61K 31/44
US Classification:
51425217, 514356
Abstract:
Compositions and methods are provided for reversing and/or inhibiting inflammation, e. g. , by inhibiting prostaglandin and/or COX-2 production, using one or more indolequinazoline alkaloids, preferably in combination with butylated hydroxytoluene. The preferred indolequinazoline alkaloids are rutaecarpine, evodiamine, and dehydroevodiamine, which are naturally found in unpurified form in the traditional Chinese medicine Wu Chu Yu made from the fruit of the herb,.

Production Of Cpd Glycosylases

View page
US Patent:
7736878, Jun 15, 2010
Filed:
Jun 29, 2006
Appl. No.:
11/478293
Inventors:
Daniel B. Yarosh - Merrick NY, US
Leonard F. Estis - Coram NY, US
Eliyahu Kraus - Sutton MA, US
Assignee:
Applied Genetics Incorporated Dermatics - Freeport NY
International Classification:
C12N 9/24
C12N 9/00
C12N 1/20
C12N 15/00
C12P 21/06
C07H 21/04
US Classification:
435200, 435 691, 435183, 4352523, 4353201, 536 232
Abstract:
Recombinant forms of DNA sequences for CPD glycosylases, including the bacteriophage T4 gene denV, are described that are capable of expression at high levels. Active CPD glycosylases can be recovered from inclusion bodies resulting from the high expression using, for example, a homogenization process which employs stream mixing, and the active proteins can be used in, for example, topical formulations for treatment of photosensitive diseases. Stream mixing can also be used to solubilize inclusion bodies containing proteins other than CPD glycosylases.

Preservation Of Ergothioneine

View page
US Patent:
8410156, Apr 2, 2013
Filed:
Jan 30, 2009
Appl. No.:
12/362594
Inventors:
Daniel B. Yarosh - Merrick NY, US
Assignee:
ELC Management, LLC - New York NY
International Classification:
A01N 43/50
A01N 37/30
A01N 47/28
A01N 41/10
A61K 31/415
A61K 31/205
A61K 31/17
A61K 31/10
US Classification:
514398, 514556, 514709, 514580
Abstract:
Compositions comprising ergothioneine and a trimethylamine absorber are provided. Also provided are methods for preventing, reducing or minimizing the fishy, amine odor, due to trimethylamine, that is associated with the processing and/or storage of a preparation containing ergothioneine, by combining with the ergothioneine, during processing or prior to storage, a trimethylamine absorber in an amount sufficient to prevent the detection of any trimethylamine odor by the human nose. A method is further provided for ameliorating the methylamine odor associated with an aqueous ergothioneine-containing preparation after it has developed a fishy trimethylamine odor.

Stabilization Of T4 Endonuclease V

View page
US Patent:
20060281166, Dec 14, 2006
Filed:
Aug 21, 2006
Appl. No.:
11/507213
Inventors:
Anne Brown - Merrick NY, US
David Brown - Merrick NY, US
Daniel Yarosh - Merrick NY, US
Assignee:
Applied Genetics - Freeport NY
International Classification:
C12N 9/22
US Classification:
435199000
Abstract:
The invention provides T4 endonuclease V compositions that exhibit enhanced stability, including stability at non-refrigerated temperatures, through reduced activity of cryptic proteases. Methods for detecting cryptic protease activity and methods for reducing such activity are also provided.

Genetic Screening For Polymorphisms In Human Genes That Increase Or Decrease Sensitivity To Toxic Agents

View page
US Patent:
20070207195, Sep 6, 2007
Filed:
Jun 7, 2005
Appl. No.:
11/628678
Inventors:
Daniel Yarosh - Merrick NY, US
David Brown - Merrick NY, US
Assignee:
Applied Genetics Incorporated Dermatics - Freeport NY
International Classification:
C12Q 1/68
A61K 9/127
G06Q 50/00
US Classification:
424450000, 435006000, 705002000
Abstract:
Methods are disclosed for genetically counseling a person based on one or more polymorphisms in his or her genes that sensitize him or her to toxic agents. Methods are also disclosed for genetically screening a group of individuals and/or a human population, based on, for example, ethnicity, race, religion or geographic region, to identify individuals with such polymorphisms for counseling. The methods can be used to counsel a person who has not been genetically tested for polymorphisms but who might have increased risk for sensitivity to toxic agents due to his or her membership in a particular group and/or population. The methods use correlations between genotypes of polymorphic alleles in a panel of cell lines and sensitivity of the cell lines to toxic agents. As examples, the methods are used to identify genotypes of allelic forms of the genes TP53, OGG1, ERCC2, XRCC1, and NOS3 that increase sensitivity or resistance of cells to toxic agents.
Daniel B Yarosh from Merrick, NY, age ~70 Get Report